What are you looking for?
In the sixth segment of The Interventional Glaucoma Project series, host Matt Jensen, of MJM / Marjen, is joined by the Omni Eye Group team: Arkadiy Yadgarov, MD, and practice administrator Kathy Disner. The group talks about how care for patients with glaucoma has evolved to offer more interventional approaches that are optimal for patients and... ...
In the fifth video in The Interventional Glaucoma Project series, Matt Jensen, of MJM / Marjen, speaks with Ben Seals, CEO of Thomas Eye...
Alain Bauza, MD, of Freehold Ophthalmology, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about a study that assessed the...
Taylor Linaburg, MD, of OCLI Vision, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about a study that found that...
In the sixth segment of The Interventional Glaucoma Project series, host Matt Jensen, of MJM / Marjen, is joined by the Omni Eye Group team: Arkadiy Yadgarov, MD, and practice administrator... ...
In the fifth video in The Interventional Glaucoma Project series, Matt Jensen, of MJM / Marjen, speaks with Ben Seals, CEO of Thomas Eye Group, and Philip Garza, MD, a glaucoma specialist... ...
Alain Bauza, MD, of Freehold Ophthalmology, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about a study that assessed the use of cryopreserved amniotic membrane in patients with...
Taylor Linaburg, MD, of OCLI Vision, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about a study that found that use of cryopreserved amniotic membranes for ocular surface...
Michael Endl, MD, of Fichte, Endl & Elmer Eyecare, spoke with Ophthalmology 360 about his presentation at the 2026 ASCRS Annual Meeting, which covered the “next generation” of intraocular lenses...
Brandon Ayres, MD, of Wills Eye Hospital, spoke with Ophthalmology 360 about the phase 1/2 data assessing investigational treatment AURN001. The 1-year results showed positive changes in best-corrected vision. Brandon...
Kenneth Beckman, MD, of Columbus Eye Surgery Center, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about his study that found that at 30 months, treatment with Epioxa...
Brian Schwam, MD, of Johnson & Johnson Vision, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about the TECNIS PureSee intraocular lens (IOL). He presented a study that...